Unknown PHASE4 INTERVENTIONAL NCT00293670

FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

Intermittent Vs Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

Sponsor: Finnish Prostate Cancer Group

Conditions Patients With T1-4 Advanced Prostate Cancer

Updated 5 times since 2017 Last updated: Feb 16, 2006 Started: May 31, 1997 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Patients With T1-4 Advanced Prostate Cancer and is currently ongoing. Finnish Prostate Cancer Group leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Apr 2019 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Apr 2019 [monthly]

Unknown Status PHASE4

First recorded

May 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Finnish Prostate Cancer Group
Tampere University

Data source: Tampere University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tampere, Finland